Stocks  /  NYSE  /  Evommune Inc.

Evommune Inc.

Industry:   Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol:   EVMN – NYSE

 

Animal Usage:   Animal Testing

Our Opinion

Evommune Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for drug testing.

Evommune utilizes the Mrgprb2 knockout mouse model (the murine ortholog of human MRGPRX2) in preclinical studies to evaluate mast cell activation, neurogenic inflammation, and pruritus (itch) pathways. Read the full document

Company Description

Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is headquartered in Palo Alto, California.

Company Website: https://www.evommune.com

Contact:  sarah.mccabe@evommune.com
Scroll to Top